|
|
Innovative Solutions for
Diastolic Heart Failure (DHF)
Over 5.7 million people in the US and 25 million people worldwide suffer from heart failure. Nearly 44% of these patients suffer from diastolic heart failure (DHF) and are without effective treatment. CorAssist is developing the first device focused on treating Diastolic Heart Failure (DHF) patients.
CorAssist is committed to developing innovative therapeutic products for treating diastolic heart failure. The company's first product, the ImCardia™ and the internal device the CORolla are the first device to directly improve cardiac diastolic function.
|
 |
ImCardia™
The company's first product, the ImCardia™, is the first device to directly improve cardiac diastolic function.
Read more..
ImCardia MIS
The ImCardia MIS is a second generation, minimally invasive version of the ImCardia device. It will allow for smaller incisions and less trauma to the patient.
Read more..
CORolla
The CORolla is an elastic device placed inside the LV through a minimally invasive or percutaneous procedure. The device applies direct expansion forces on the LV wall and the septum.
Read more..
|
